Skip to content

Clinical trials

Trials in Jordan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Country / region: Jordan Clear all

691 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20046
20051
20064
20079
20088
200913
20107
20114
201215
201310
201431
201515
201628
201741
201844
201949
202052
202152
202263
202354
202459
202576
202643

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed417
Unknown status79
Recruiting66
Active, not recruiting56
Not yet recruiting25
Terminated21
Enrolling by invitation14
Withdrawn10
No longer available2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Jordan112
Jordan University of Science and Technology79
King Abdullah University Hospital52
Novartis Pharmaceuticals35
Jordan Collaborating Cardiology Group23
King Hussein Cancer Center21
Applied Science Private University16
Bayer13
Al-Zaytoonah University of Jordan11
Humanis Saglık Anonim Sirketi11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus23
Diabetes Mellitus, Type 221
Breast Neoplasms20
Pain19
Multiple Sclerosis15
COVID-1914
Insulin Resistance13
Hypertension12
Anxiety Disorders10
Carcinoma, Non-Small-Cell Lung10

Trials

Showing 76 to 100 of 691. Each trial links to its page on Pharma Observatory.

591 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.